NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Change in Accured Expenses (2010 - 2026)

NextPlat's (NXPL) quarterly Change in Accured Expenses came in at $1.8 million in Q2 2026, up 178.2% year-over-year from $650981.8 in Q2 2025, and up 2563.24% quarter-over-quarter from $68000.0 in Q1 2026.

Analysis

NextPlat (NXPL) Change in Accured Expenses (2010 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Change in Accured Expenses for 16 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses rose 178.2% year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $5.1 million, a 175.84% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 119.44% from the prior year.
  • Change in Accured Expenses was $1.8 million for Q2 2026 at NextPlat, up from $68000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $4.4 million in Q3 2023 and troughed at -$3.3 million in Q3 2024.
  • A 5-year average of $38944.4 and a median of $81000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses surged 323228.38% in 2023 and plunged 843.29% in 2024, its largest moves.
  • Over 5 years, Change in Accured Expenses stood at $429300.0 in 2022, then slumped by 306.62% to -$887000.0 in 2023, then slumped by 56.71% to -$1.4 million in 2024, then surged by 246.69% to $2.0 million in 2025, then slipped by 11.18% to $1.8 million in 2026.
  • The last three Change in Accured Expenses figures came in at $1.8 million (Q2 2026), $68000.0 (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 82.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn -111.90 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 66.66 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 73.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn -
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 3.62 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 1.96 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 1.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.81 Mn
Mar 31, 2026 68,000.00
Dec 31, 2025 2.04 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 -2.32 Mn
Mar 31, 2025 239,000.00
Dec 31, 2024 -1.39 Mn
Sep 30, 2024 -3.30 Mn
Jun 30, 2024 -3.09 Mn
Mar 31, 2024 1.75 Mn
Dec 31, 2023 -887,000.00
Sep 30, 2023 4.35 Mn
Jun 30, 2023 -328,000.00
Mar 31, 2023 94,000.00
Dec 31, 2022 429,300.00
Sep 30, 2022 1,346.00
Jun 30, 2022 -329,847.00
Mar 31, 2022 352,201.00
Dec 31, 2021 179,298.00
Sep 30, 2021 -830,579.00